New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. However the study suggests that if a man's PSA level is rising quickly, a prostate biopsy is reasonable to determine if he has prostate cancer. These findings are being presented this week at the North Central Section of the American Urological Association in Scottsdale, Ariz.
- Routine evaluation of prostate size not as effective in cancer screening, Mayo study findsTue, 10 Nov 2009, 11:24:51 EST
- Prostate cancer survival rates improved since introduction of PSA testingThu, 23 Aug 2012, 10:09:48 EDT
- When rising PSA means prostate cancer is in patient's futureWed, 18 May 2011, 12:05:44 EDT
- Genetic mutations associated with increased PSA and prostate cancerThu, 2 Dec 2010, 14:06:00 EST
- New blood test greatly reduces false-positives in prostate cancer screeningThu, 28 May 2009, 11:46:01 EDT